M
Microvisk Technologies
MEMS-based coagulation monitoring for point-of-care testing
About Microvisk Technologies
Microvisk Technologies is a medical device company that developed a point-of-care coagulation monitoring system. The firm was founded in 2004 as a spin-out from the UK's Science and Technology Facilities Council, with initial backing from the Rainbow Seed Fund. The company's main facility is in Oxford, UK.
The core of Microvisk's offering is a system for patients on anticoagulant drugs like Warfarin to monitor their blood clotting time, measured as the prothrombin time (PT) or International Normalised Ratio (INR). The system comprises a handheld reader and disposable test strips, branded as the 'SmartStrip®'. This technology is based on a patented Micro-Electro-Mechanical System (MEMS), a departure from the optical or chemical reaction methods used by other devices on the market. The MEMS chip features a tiny cantilever that physically moves within a single drop of blood to measure its viscosity, allowing for direct clot detection. This solid-state system was designed to be robust, require a smaller blood sample, and be simpler for home use, much like a glucose monitor.
The company developed two main devices: the 'CoagMax®' for point-of-care professional use and the 'CoagLite®' for patient self-testing at home. The business model focused on selling these handheld monitors and the recurring revenue from the disposable SmartStrips. These strips contain a memory chip that stores calibration and batch data, which is automatically uploaded to the reader to improve accuracy and ease of use. The devices aimed to serve the millions of patients on long-term anticoagulation therapy who require frequent monitoring, offering a more convenient alternative to regular clinic visits. After securing significant funding from investors including Porton Capital, Oxford Technology Management, Midven, and Finance Wales, Microvisk initiated clinical trials and prepared for product launches in the UK, Germany, and the US around 2011-2012. According to a public filing, the company was acquired or merged in May 2016.
Source: Dealroom company dataAt a glance
- Founded
- 2004
- Headquarters
- Oxford, United Kingdom
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Future Planet Capital- PGPorton Group
Series B and later3 investors entered at this stage
Oxford Technology
Finance Wales
Future Planet Capital Regional
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Microvisk Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Microvisk Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.